Neostigmine Methylsulfate

Generic: Neostigmine Methylsulfate

Labeler: Hikma Pharmaceuticals USA Inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Active

Drug Facts

Product Profile

Brand Name Neostigmine Methylsulfate
Generic Name Neostigmine Methylsulfate
Labeler Hikma Pharmaceuticals USA Inc.
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

NEOSTIGMINE METHYLSULFATE 1 mg/mL

Identifiers & Regulatory

Product NDC 0641-6240
Product ID 0641-6240_8dab3acb-37f7-4e23-8a3f-7508d5f60978
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216206
Listing Expiration 2026-12-31
Marketing Start 2022-07-13

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06416240
Hyphenated Format 0641-6240

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Neostigmine Methylsulfate (source: ndc)
Generic Name Neostigmine Methylsulfate (source: ndc)
Application Number ANDA216206 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 10 SYRINGE, PLASTIC in 1 CARTON (0641-6240-10) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (1)

Ingredients (1)

NEOSTIGMINE METHYLSULFATE (1 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8dab3acb-37f7-4e23-8a3f-7508d5f60978", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["2105413"], "spl_set_id": ["9afefbea-ea4a-48c5-ba51-42ece652eb7d"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE, PLASTIC in 1 CARTON (0641-6240-10)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0641-6240-10", "marketing_start_date": "20220713"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "0641-6240_8dab3acb-37f7-4e23-8a3f-7508d5f60978", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0641-6240", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA216206", "marketing_category": "ANDA", "marketing_start_date": "20220713", "listing_expiration_date": "20261231"}